CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Bristol Myers Reverses Lower Despite Double Phase 3 Win, As A Key Rival Crashes

Phase 3positivePositive
AI Analysis

Summary

Bristol Myers Squibb achieved positive Phase 3 trial results with a double win, though the stock declined despite the favorable clinical data.

Clinical Trial Data

Phase

3

Primary Endpoint

Met

Outcome Details

Double Phase 3 win

Importance:7/10
Sentiment:
0.30
Phase_3Clinical_TrialPositive_Data
Related Companies

Read the original article

Published by yahoo_finance on October 12, 2026 8:14 PM

Read Original